About: Open PHACTS   Sponge Permalink

An Entity of Type : dbkwik:resource/_oyQKPcBSZR9S_xP9erLCA==, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

Open PHACTS (Open Pharmacological Concept Triplestone) is public-private partnership between academia, publishers, enterprises, pharmaceutical companies and other organisations working to enable better, cheaper and faster drug discovery. It has been funded under a European grant from the Innovative Medicines Initiative . A total of 27 partners are currently involved including:

AttributesValues
rdf:type
rdfs:label
  • Open PHACTS
rdfs:comment
  • Open PHACTS (Open Pharmacological Concept Triplestone) is public-private partnership between academia, publishers, enterprises, pharmaceutical companies and other organisations working to enable better, cheaper and faster drug discovery. It has been funded under a European grant from the Innovative Medicines Initiative . A total of 27 partners are currently involved including:
dcterms:subject
dbkwik:speedydelet...iPageUsesTemplate
Formation
  • 2011(xsd:integer)
Name
  • Open PHACTS
Type
Key people
Purpose
  • Deliver and sustain an Open Pharmacological Space
Motto
  • Semantic interoperability for drug discovery
Size
  • frameless
abstract
  • Open PHACTS (Open Pharmacological Concept Triplestone) is public-private partnership between academia, publishers, enterprises, pharmaceutical companies and other organisations working to enable better, cheaper and faster drug discovery. It has been funded under a European grant from the Innovative Medicines Initiative . A total of 27 partners are currently involved including: * Academia: Maastricht University, the University of Santiago de Compostela, The University of Vienna the University of Manchester, the University of Bonn, the Swiss Institute of Bioinformatics, the European Bioinformatics Institute, the Vrije Universiteit of Amsterdam, the Technical University of Denmark and the University of Hamburg * Pharmaceutical companies: Pfizer, Merck KGaA, Eli Lilly and Company, Novartis, GlaxoSmithKline and AstraZeneca * enterprises: ChemSpider * publishers: Royal Society of Chemistry The Open Pharmacological Space created by the consortium is intended to facilitate improvements in drug discovery and to support open innovation and in-house non-public drug discovery research. Resources from the project are available on GitHub
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software